The Valley Desk

ReviewJACC. AsiaPublished

SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Jefferson Einstein Philadelphia Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Review
Venue
JACC. Asia
Published
Subject terms
Inflammation; Mitral valve; Rheumatic heart disease; epidemiology; Valvular Heart Disease; Translational Science; Basic Science; Rheumatic Heart Valve Disease
PubMed ID
42233563
PubMed Central ID
PMC13244101
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal